Literature DB >> 26675403

Retinal fibrosis in diabetic retinopathy.

Sayon Roy1, Shruti Amin2, Sumon Roy2.   

Abstract

In response to injury, reparative processes are triggered to restore the damaged tissue; however, such processes are not always successful in rebuilding the original state. The formation of fibrous connective tissue is known as fibrosis, a hallmark of the reparative process. For fibrosis to be successful, delicately balanced cellular events involving cell proliferation, cell migration, and extracellular matrix (ECM) remodeling must occur in a highly orchestrated manner. While successful repair may result in a fibrous scar, this often restores structural stability and functionality to the injured tissue. However, depending on the functionality of the injured tissue, a fibrotic scar can have a devastating effect. For example, in the retina, fibrotic scarring may compromise vision and ultimately lead to blindness. In this review, we discuss some of the retinal fibrotic complications and highlight mechanisms underlying the development of retinal fibrosis in diabetic retinopathy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetic retinopathy; Extracellular matrix; Müller cell; Retinal fibrosis; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2016        PMID: 26675403      PMCID: PMC4683353          DOI: 10.1016/j.exer.2015.04.004

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  67 in total

Review 1.  The role of Müller cells in fibrocontractive retinal disorders.

Authors:  Clyde Guidry
Journal:  Prog Retin Eye Res       Date:  2005-01       Impact factor: 21.198

2.  Combined rhegmatogenous and traction retinal detachment in proliferative diabetic retinopathy: clinical manifestations and surgical outcome.

Authors:  Chung-May Yang; Pei-Yuang Su; Po-Ting Yeh; Muh-Shy Chen
Journal:  Can J Ophthalmol       Date:  2008-04       Impact factor: 1.882

3.  Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye.

Authors:  Esther J Kuiper; Marc D de Smet; Jan C van Meurs; H Stevie Tan; Michael W T Tanck; Noelynn Oliver; Frans A van Nieuwenhoven; Roel Goldschmeding; Reinier O Schlingemann
Journal:  Arch Ophthalmol       Date:  2006-10

4.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.

Authors:  R H Amin; R N Frank; A Kennedy; D Eliott; J E Puklin; G W Abrams
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-01       Impact factor: 4.799

5.  Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Müller cells.

Authors:  T Cheng; W Cao; R Wen; R H Steinberg; M M LaVail
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-03       Impact factor: 4.799

6.  Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.

Authors:  Shinsuke Miyahara; Junichi Kiryu; Kenji Yamashiro; Kazuaki Miyamoto; Fumitaka Hirose; Hiroshi Tamura; Hideto Katsuta; Kazuaki Nishijima; Akitaka Tsujikawa; Yoshihito Honda
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.

Authors:  R Meyer-Schwickerath; A Pfeiffer; W F Blum; H Freyberger; M Klein; C Lösche; R Röllmann; H Schatz
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 8.  The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.

Authors:  Ulrike Muscha Steckelings; Franziska Rompe; Elena Kaschina; Thomas Unger
Journal:  Fundam Clin Pharmacol       Date:  2009-10-09       Impact factor: 2.748

9.  Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders.

Authors:  Ahmed M Abu El-Asrar; Mohd Imtiaz Nawaz; Dustan Kangave; Mohammed Mairaj Siddiquei; Karel Geboes
Journal:  Mediators Inflamm       Date:  2012-09-29       Impact factor: 4.711

10.  IL-10 is significantly involved in HSP70-regulation of experimental subretinal fibrosis.

Authors:  Yang Yang; Atsunobu Takeda; Takeru Yoshimura; Yuji Oshima; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more
  29 in total

Review 1.  Research Progress in MRI of the Visual Pathway in Diabetic Retinopathy.

Authors:  Yu-Min Li; Hong-Mei Zhou; Xiang-Yang Xu; He-Shui Shi
Journal:  Curr Med Sci       Date:  2018-12-07

Review 2.  Minireview: Fibronectin in retinal disease.

Authors:  Charles G Miller; Greg Budoff; Jonathan L Prenner; Jean E Schwarzbauer
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-20

3.  Proteomic analysis of anti-angiogenic effects by conbercept in the mice with oxygen induced retinopathy.

Authors:  Ji Jin; Lei Chen; Gao-Qin Liu; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

Review 4.  Immune Cells in Subretinal Wound Healing and Fibrosis.

Authors:  Manon Szczepan; María Llorián-Salvador; Mei Chen; Heping Xu
Journal:  Front Cell Neurosci       Date:  2022-06-10       Impact factor: 6.147

5.  mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy.

Authors:  Steven Hyun Seung Lee; Joo Yong Lee; Jun-Sub Choi; Hee Jong Kim; Jin Kim; Seho Cha; Kyoung Jin Lee; Ha-Na Woo; Keerang Park; Heuiran Lee
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

6.  Dopamine receptor signaling regulates fibrotic activation of retinal pigmented epithelial cells.

Authors:  Ashley Y Gao; Patrick A Link; Sophie J Bakri; Andrew J Haak
Journal:  Am J Physiol Cell Physiol       Date:  2022-05-11       Impact factor: 5.282

7.  Light deprivation reduces the severity of experimental diabetic retinopathy.

Authors:  Christina Thebeau; Sheng Zhang; Alexander V Kolesnikov; Vladimir J Kefalov; Clay F Semenkovich; Rithwick Rajagopal
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

Review 8.  Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets.

Authors:  Harshini Chakravarthy; Vasudharani Devanathan
Journal:  J Mol Neurosci       Date:  2018-10-06       Impact factor: 3.444

9.  Assessment of circulating fibrotic proteins (periostin and tenascin -C) In Type 2 diabetes mellitus patients with and without retinopathy.

Authors:  A Indumathi; Gandhipuram Periyaswamy Senthilkumar; Kuppuswamy Jayashree; K Ramesh Babu
Journal:  Endocrine       Date:  2022-03-10       Impact factor: 3.925

10.  In Vivo Evaluation of the Visual Pathway in Streptozotocin-Induced Diabetes by Diffusion Tensor MRI and Contrast Enhanced MRI.

Authors:  Swarupa Kancherla; William J Kohler; Yolandi van der Merwe; Kevin C Chan
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.